Skip to content
WELCOME10 — 10% OFFSHOP NOW →
Research Explainer6 min read

What is SS-31 (elamipretide)? The mitochondrial peptide explained

SS-31 is a four-amino-acid synthetic peptide, also called elamipretide, Bendavia or MTP-131. It concentrates in the inner membrane of mitochondria and binds a lipid called cardiolipin. This guide covers where it acts, what the lab studies and the one small human trial actually measured, and what a research vial costs in Canada.

what is ss-31ss-31 peptideelamipretidecardiolipinmitochondriass-31 canada
By Popular PeptidesPublished

SS-31 is a synthetic peptide made of four amino acids, also known as elamipretide, Bendavia or MTP-131. It belongs to the Szeto-Schiller family of peptides and is designed to concentrate in the inner membrane of mitochondria, where it binds a lipid called cardiolipin. Most published research on SS-31 is in cells and animals, with a small number of human trials.

Ready to look at the vial? Shop SS-31 10 mg · $59.99 or message Kobi on WhatsApp with a question first.

SS-31 in one paragraph

SS-31 has a short sequence: D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2′,6′-dimethyltyrosine. The name “SS-31” is the original lab code from the Szeto-Schiller (SS) series of peptides, built around alternating aromatic and positively charged amino acids. “Elamipretide” is the nonproprietary name for the same molecule, and “MTP-131” and “Bendavia” are names it picked up during development. If you see all four in one thread, they are one compound, not four. You can read the full sequence and handling notes on the SS-31 research page.

Where SS-31 acts: cardiolipin and the inner mitochondrial membrane

Mitochondria are the cell’s energy-producing compartments, and their inner membrane carries the electron transport chain. That membrane is unusually rich in cardiolipin, a lipid that helps hold the chain’s protein complexes in place. Cytochrome c, an electron carrier, also interacts with cardiolipin.

That is why researchers are interested in a peptide that binds cardiolipin. In a 2014 *British Journal of Pharmacology* study from Weill Cornell, SS-31 interacted only with liposomes and bicelles (artificial lipid bilayers) that contained cardiolipin, and NMR work showed its aromatic residues penetrating deep into the cardiolipin-containing bilayers. In fresh mitochondria from that study, SS-31 increased state 3 respiration and the efficiency of ATP synthesis. Those are measurements in a dish, not in a person, and they describe a mechanism rather than an outcome.

What the research has looked at

Early lab studies

A 2004 paper in the *Journal of Biological Chemistry* described cell-permeable peptide antioxidants aimed at the inner mitochondrial membrane. Working in cultured cells and isolated mitochondria, the group reported that these peptides concentrated about 1,000-fold in the inner membrane, reduced mitochondrial reactive oxygen species, and inhibited mitochondrial swelling and cytochrome c release in those models. They also tested the peptides in an ex vivo heart model. Peptide analogs without the dimethyltyrosine residue did not show the same effects, which is how the authors pointed to that residue as the key part of the design.

The human trial most often cited

The study that gets quoted most often is a 2018 paper in *Neurology* (the MMPOWER trial). Here is what its abstract says, and only that:

  • —Design: a phase I/II, multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial.
  • —Who: 36 adults with genetically confirmed primary mitochondrial myopathy, a group of inherited mitochondrial disorders.
  • —How it was given: by intravenous infusion over 2 hours, for 5 days, at three escalating dose levels or placebo.
  • —What it measured: the primary measure was the change in distance walked in the 6-minute walk test after 5 days. Other measures included cardiopulmonary exercise testing, participant-reported symptoms, blood and urine biomarkers, safety and pharmacokinetics.
  • —What it found: at the highest dose, participants walked a mean of 64.5 m farther at day 5, against a change of 20.4 m in the placebo group (p = 0.053). There was a dose-dependent trend in the walk distance (p = 0.014), and an adjusted model gave 51.2 m against 3.0 m (p = 0.0297). The abstract also reports no significant differences in the other efficacy and safety endpoints, and the authors write that the findings remain to be tested in larger trials with longer dosing periods.

Two cautions are worth keeping next to those numbers. The first walk-distance comparison did not reach the usual p < 0.05 line, and the trial was small and short. The trial also used a clinical intravenous formulation in people with a specific diagnosis, so it cannot be read as a result for any freeze-dried research vial or for anyone outside that group. One of the authors is affiliated with Stealth BioTherapeutics, the company developing elamipretide.

What the research doesn’t show

There are no trials in healthy people looking at ageing or performance. Most of the evidence for SS-31 comes from cells, isolated mitochondria and animal models, and findings at that level often do not carry over to people. Anyone telling you SS-31 does a particular thing in a healthy adult is going beyond the published record, and this post will not do that.

SS-31 vs MOTS-c and NAD+, briefly

These three often show up in the same longevity threads, but they are different kinds of molecule. SS-31 is a peptide that sits at the inner mitochondrial membrane and binds cardiolipin. MOTS-c is a peptide encoded in mitochondrial DNA, studied mostly in mice. NAD+ is a coenzyme that cells use throughout metabolism. For the side-by-side, see SS-31 vs MOTS-c and our longer comparison, NAD+ vs MOTS-c: cellular longevity research compared. If you are browsing the neighbours, MOTS-c 10 mg is $39.99 and NAD+ 500 mg is $59.99. All three sit in the Longevity collection.

Buying SS-31 in Canada

Here is what the product page shows today (18 November 2026):

  • —SS-31 10 mg freeze-dried vial: $59.99 CAD, ≥99% HPLC purity.
  • —Volume pricing: 3–5 vials at $53.99 each (10% off) and 6 or more at $50.99 each (15% off).
  • —Bacteriostatic water add-on: $9.99.
  • —Shipping: from Vancouver by Canada Post Xpresspost with tracking. Orders are usually dispatched within 1–2 business days, and delivery times by province are on the shipping page.
  • —Free shipping on orders over $300 CAD.
  • —Offers: 10% off a first order with code WELCOME10, and ~10% off when you pay by Interac e-Transfer.
  • —Storage: see the SS-31 storage notes.

Batches are third-party tested for HPLC purity, and certificates of analysis are for members only.

Add it to your cart: Shop SS-31 10 mg · $59.99. Or ask Kobi a question on WhatsApp.

FAQ

What is SS-31?

SS-31 is a synthetic peptide made of four amino acids, also known as elamipretide, Bendavia or MTP-131. It is one of the Szeto-Schiller peptides, designed to concentrate in the inner membrane of mitochondria, where it binds cardiolipin, a lipid that helps organise the cell’s energy-producing machinery. Most published research on SS-31 is in cells and animals, with a small number of human trials.

What has SS-31 been studied for?

Early lab studies, published in 2004, tested SS-31 and related peptides in models of mitochondrial swelling and oxidative cell death. Later work focused on how it binds cardiolipin in the inner mitochondrial membrane. In humans, a small randomized dose-escalation trial published in 2018 tested intravenous elamipretide in 36 adults with primary mitochondrial myopathy, a group of inherited mitochondrial disorders, and measured the change in 6-minute walk distance after five days.

Where can I buy SS-31 in Canada?

Popular Peptides sells SS-31 as a 10 mg freeze-dried research vial for $59.99 CAD, or $53.99 each for 3–5 vials and $50.99 each for 6 or more. Orders ship from Vancouver by tracked Xpresspost, usually dispatched within 1–2 business days, with free shipping on orders over $300.

Sources

Every source below was opened and checked against PubMed or Crossref on 18 November 2026.

  • —Zhao K, Zhao GM, Wu D, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. *J Biol Chem* 2004;279(33):34682–90. PubMed 15178689
  • —Birk AV, Chao WM, Bracken C, Warren JD, Szeto HH. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. *Br J Pharmacol* 2014;171(8):2017–28. PubMed 24134698
  • —Karaa A, Haas R, Goldstein A, Vockley J, Weaver WD, Cohen BH. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy. *Neurology* 2018;90(14):e1212–e1221. PubMed 29500292

Ask Kobi

Got a question about SS-31 for your research? Kobi runs a free Canadian peptide info line: Message Kobi on WhatsApp.

When you are ready, Shop SS-31 10 mg · $59.99.

Research peptides. Minus the hype.

Key takeaways

  • SS-31 is a synthetic four-amino-acid peptide (D-Arg-Dmt-Lys-Phe-NH2), also called elamipretide, Bendavia or MTP-131.
  • It is designed to concentrate in the inner mitochondrial membrane, where it binds cardiolipin; the binding work was done in liposomes, bicelles and isolated mitochondria.
  • The best-known human study is a 36-person, five-day randomized trial in adults with primary mitochondrial myopathy, given intravenously. It says little about healthy people.
  • Most SS-31 research is in cells and animals. Popular Peptides sells SS-31 as a 10 mg research vial for $59.99 CAD, with 3–5 vials at $53.99 each and 6 or more at $50.99 each.

We source from distributors whose batches are third-party tested for HPLC purity and measured content. Certificates of Analysis (COAs) are for members only.